(Q45866209)
Statements
Interleukin 2 gene therapy of surgical minimal residual tumour disease: characterization of cytolytic effector cells from tumour progressors and regressors (English)
Hájková R
Indrová M
Jandlová T
Bubeník J
scientific article published in January 1999